Acetazolamide Tablet
Product Images NDC 64380-834

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 64380-834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E0a3495b 7944 4433 Bba6 057a4ea81f7e 01

FDA Label Image

E0a3495b 7944 4433 Bba6 057a4ea81f7e 02

Each tablet contains 125 mg of Acetazolamide. It is manufactured by Strides Pharma Science Ltd. in India and distributed by Strides Pharma Inc. in East Brunswick, NJ. The medication should be stored between 20-25°C (68-77°F) in a well-closed container as defined by USP. Full prescribing information is available in the insert.*

FDA Label Image

E0a3495b 7944 4433 Bba6 057a4ea81f7e 03

This is a medication containing Acetazolamide, USP 250 mg and it is recommended to store it at 20° to 25°C (68° to 77°F). The manufacturer is Strides Pharma Science Ltd., based in Puducherry, India, and it is distributed by Strides Pharma Inc. in East Brunswick, NJ. It should be dispensed in well-closed containers as defined in the USP. However, the rest of the text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.